NYU Langone and NYU Grossman in the News
New York Post
Following a measles-related death in New York, the first in over 30 years, an article explains why booster shots are necessary for some vaccines but not others. According to Isaac P. Dapkins, MD, an internal and pediatric specialist and chief medical officer of the Family Health Centers at NYU Langone Health, the need for boosters depends on how much an infection changes and the duration of immune protection. Viruses like influenza mutate rapidly, requiring
Adapting medical education to AI is a must. Here's why.
HealthLeaders
NYU Grossman School of Medicine is integrating artificial intelligence into medical education to enhance learning while addressing concerns about over-reliance on technology. Jesse Burk Rafel, MD, MRes, assistant director and vice chair for research at NYU Grossman School of Medicine's Institute for Innovations in Medical Education, co-authored a viewpoint on the topic. The school's AI Clinical and Operational Readiness in Education course trains students and residents to work with AI tools. Other innovations include Communication Compass for bedside manner coaching, GradeGPT for feedback on clinical notes, and Diagnosis AId, which provides real-time feedback on a learner's diagnostic thinking process.
11/04/2026
PhD candidate Amira Gee runs the NYC Marathon to raise diabetes awareness
New York Amsterdam News
Amira Gee, a population health PhD candidate at the NYU Grossman School of Medicine, who has type 1 diabetes, completed her first TCS New York City Marathon. Running with the Beyond Type 1 nonprofit team during Diabetes Awareness Month, Gee aimed to raise awareness for the condition. She described the daily management of type 1 diabetes as a marathon in itself, requiring constant endurance and calculations. Gee hopes her personal achievement of finishing the 26.2-mile race demonstrates that anything is possible for those living with diabetes.
11/05/2026
NYC marathon runner collapses two miles from finish, dies from 'extremely rare' condition
Fox News
Devi E. Nampiaparampil, MD, clinical associate professor in the Department of Rehabilitation Medicine at NYU Grossman School of Medicine, explains the warning signs of rhabdomyolysis following the death of a runner just two miles from the finish of the NYC marathon.
11/04/2026
Good Housekeeping (UK)
Several neurologists outline daily habits to boost brain health and lower dementia risk, including prioritizing sleep, avoiding smoking, and regular exercise. Arjun Masurkar, MD, PhD, associate professor of neurology and neuroscience at NYU Grossman School of Medicine, highlights that the U.S. POINTER study demonstrated how a healthy diet, exercise, intellectual stimulation, social engagement, and cardiovascular monitoring improved cognitive performance. He adds that stress contributes to poor sleep, unhealthy eating, and high blood pressure, which can damage the brain. Other advice includes managing mental health and limiting alcohol consumption.
Also reporting was: MSN UK, Yahoo Life UK
11/04/2026
Perlmutter Cancer Center names director of early-phase drug development and rare cancer programs
The ASCO Post
NYU Langone Health has appointed Vivek Subbiah, MD, as director of the Early Phase Drug Development Program and the Rare Tumor Program at Perlmutter Cancer Center, effective November 1. He will also serve as a professor in the Department of Medicine at NYU Grossman School of Medicine. Anirban Maitra, MD, director of the Perlmutter Cancer Center, welcomed the expertise he brings to early-phase trials. John P. Leonard, MD, chief of the Division of Hematology and Medical Oncology at NYU Grossman School of Medicine and Chief Clinical Officer for Enterprise Cancer Strategy and Operations at Perlmutter Cancer Center, also commented on the appointment.
11/04/2026
Tumor-agnostic therapies advance precision oncology through comprehensive biomarker testing
Oncology Learning Network
Following a presentation, Vivek Subbiah, MD, medical oncologist, director for Early Phase Drug Development program and Rare Tumor program at NYU Langone's Perlmutter Cancer Center, discusses the expanding role of tumor-agnostic precision oncology. He emphasizes using comprehensive biomarker testing, including next-generation sequencing and immunohistochemistry, to guide individualized cancer treatment. Dr. Subbiah explains the importance of distinguishing between detected, actionable, and druggable molecular alterations to match the right patient with the right therapy. He reviews tumor-agnostic treatment opportunities involving biomarkers like BRAF, NTRK, RET, and HER2, noting that disease context and prior treatments influence interpretation and treatment selection.
11/04/2026
Biomarker sequencing, PD-L1 status, and FLOT dosing in gastroesophageal cancer
ONCOLOGY journal
In an interview, Rutika Mehta, MD, MPH, director of Upper Gastrointestinal (GI) Medical Oncology at NYU Langone Health’s Perlmutter Cancer Center, discussed practical considerations for managing gastroesophageal cancer. Mehta explained her process for sequencing biomarker testing to conserve tissue, prioritizing HER2, claudin 18.2, and PD-L1. She also covered treatment selection for patients with PD-L1–low disease, her framework for FLOT dose modifications to manage toxicity, the importance of early medical oncology referrals, and the future role of ctDNA in guiding treatment strategies in clinical trials.
11/04/2026
ESMO: Sacituzumab tirumotecan is beneficial for endometrial cancer
Cancer Therapy Advisor
Research presented at the ESMO Congress 2026 found that sacituzumab tirumotecan significantly improves progression-free and overall survival for patients with advanced or recurrent endometrial cancer. The objective response rate was also higher compared to the physician’s choice of treatment. According to the study's principal author, Bhavana Pothuri, MD, professor in the Departments of Obstetrics and Gynecology, and Medicine at NYU Grossman School of Medicine and director of gynecologic oncology clinical trials at NYU Langone Health’s Perlmutter Cancer Center, the results are practice-changing and will require clinical guidelines to be reassessed to incorporate the new drug. The study was funded by manufacturer Merck.
11/04/2026
Distinguishing Lambert-Eaton myasthenic syndrome from ocular myasthenia gravis in the eye clinic
NeurologyLive
In an interview, Kiril Kiprovski, MD, clinical professor of neurology and director of NYU Langone's Division of Neuromuscular Medicine, outlines how clinicians can distinguish Lambert-Eaton myasthenic syndrome (LEMS) from ocular myasthenia gravis. Kiprovski explains that LEMS typically presents with proximal leg weakness and reduced reflexes, while myasthenia gravis primarily affects eye muscles. He notes that identifying LEMS is critical as about half of cases are linked to small cell lung cancer. The article also reviews key bedside tests and the different treatment approaches for each condition.
11/04/2026
Advanced imaging uncovers genomic Achilles' heel that makes cancer cells vulnerable
Medical Xpress
A study led by researchers at NYU Langone Health and its Perlmutter Cancer Center shows that specific vulnerable DNA sites can make cancer cells highly sensitive to PARP inhibitors. Published in Nature Cell Biology, the research identifies how DNA replication failures at critical chromosome regions determine a cancer cell's vulnerability to these drugs. The team, including co-corresponding author Eli Rothenberg, PhD, professor in the Department of Biochemistry and Molecular Pharmacology at NYU Grossman School of Medicine, used advanced imaging to pinpoint these sites. The findings may help develop new biomarkers to predict treatment response.
Also reporting was: MSN
11/05/2026
Key gene preserves lifelong supply of stem cells that make bone healing possible, study suggests
Medical Xpress
A new study led by NYU Langone Health researchers found that the gene HOXA10 is required to maintain a lifelong supply of bone-healing stem cells. Published in Science Advances, the findings show HOXA10 preserves stem cell pools by preventing their premature maturation into bone-building cells. According to corresponding author Philipp Leucht, MD, PhD, the Jyoti Menon Associate Professor of Orthopedic Surgery and vice chair for research in the Department of Orthopedic Surgery at NYU Grossman School of Medicine, mice engineered to lack the gene could not heal properly after a fracture. The results establish HOX genes as potential therapeutic targets for enhancing bone regeneration.
Also reporting was: Genetic Engineering & Biotechnology News, MSN UK, Lifeboat Foundation
11/04/2026
Brain activity patterns may predict Alzheimer's years before memory slips
Medical Xpress
Stanford Medicine-led research suggests specific brain activity patterns may predict the likelihood of developing Alzheimer's disease years before symptoms appear. Researchers developed a scoring system, the Alzheimer's resilience-vulnerability connectome (ARC) score, by comparing the brains of cognitively resilient 'super agers' with those of Alzheimer's patients. This score proved more effective at predicting cognitive decline than existing biomarkers and genetics. The findings may allow for earlier interventions. Researchers from several institutions, including NYU Grossman School of Medicine, contributed to the work, which was published in Science Advances.
Also reporting was: News Medical, UK Head Topics, MSN UK
11/04/2026
Cardiovascular Business
The ProtEmbo Cerebral Protection System, an investigational device for preventing stroke during transcatheter aortic valve replacement, failed to meet its primary efficacy endpoint in a clinical trial. Susheel Kodali, MD, interventional cardiologist at NYU Langone Health, presented the late-breaking data, which led to the trial being stopped early. Kodali stated there is no evidence to support the device's adoption and that the results add uncertainty to the routine use of cerebral embolic protection, questioning how to best measure benefit and identify high-risk patients moving forward.
11/04/2026
Nighttime eating: Strategies to help patients cut back
Medscape
An article on managing nighttime eating habits features expert commentary from Diane A. Klein, MD, clinical associate professor in NYU Langone's Department of Psychiatry. She notes that patients often snack at night due to stress, tiredness, or undereating during the day, which can become a habit. Dr. Klein recommends strategies such as conducting a 24-hour dietary recall to identify deficits, ensuring regular and nutritionally adequate meals, improving sleep, and planning evening snacks. The article also touches upon research linking late-night eating to health risks like liver and cerebrovascular disease.
11/05/2026
Nail health: A category ripe for consolidation?
HAPPI
In an opinion piece, Seth J. Orlow, MD, PhD, the Rudolf L. Baer Professor of Dermatology and chair of the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine, argues that “nail health” is a distinct, unorganized market category ripe for consolidation. He defines the category as nonprescription products that improve the natural nail, noting the market is estimated to be between $1.8 billion and $3.2 billion. Orlow suggests key drivers include an aging population and post-manicure recovery needs. He posits that a strategic consolidator, such as a consumer health company or private equity fund, could build a leading business by unifying this fragmented space.
11/04/2026
Grandparents urged to get measles, flu, and other shots before meeting a newborn in the U.S.
WMTW TV News 8
An article urges grandparents to ensure they are up to date on vaccinations for measles, flu, COVID-19, and whooping cough before visiting a newborn. The piece highlights that babies are particularly vulnerable in their first six months and rely on the immunity of those around them. Celine R. Gounder, MD, an infectious disease specialist at NYU Langone Health, advises that an updated COVID-19 shot protects both the recipient and reduces the risk of transmitting the virus to vulnerable family members. She also recommends getting another MMR shot if there is uncertainty about measles immunity.
11/04/2026
Repeat prostate biopsies: Will the antibiotic used last time still work?
The Active Surveillor
A 2024 study by researchers at NYU Langone Health and NYU Grossman School of Medicine examined antibiotic resistance in men being evaluated for prostate biopsies. The research, led by Alex J. Xu, MD, then resident in the Department of Urology, with senior author James S. Wysock, MD, associate professor in the Department of Urology, was published in The Canadian Journal of Urology. The study reviewed rectal cultures from 743 men, finding that 22% carried bacteria resistant to ciprofloxacin. Factors associated with resistance included diabetes, prior use of the antibiotic, and three or more previous prostate biopsies.
11/05/2026
Girl Scouts of Nassau County hosts clinic to teach daisies safety skills
Patch
Experts from the Trauma Center at NYU Langone Hospital—Long Island recently hosted a Stuffie Care Clinic for the Girl Scouts of Nassau County. The program taught Girl Scout Daisies important safety skills, like basic first aid, bicycle helmet use, and car-passenger safety. Josephine Peterson, MPH, injury prevention specialist at NYU Langone Hospital—Long Island, noted that teaching simple safety habits early can prevent serious injuries. The event provided a hands-on way for young girls to build confidence, learn how to stay safe, and get an early look at careers in healthcare.
11/04/2026